Therapeutic agents
CA 2376213 A1 · Owner: Birch, Alan Martin · Inventors: Birch, Alan Martin; Heal, David John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for the treatment of obesity and associated co-morbid conditions in a human in need of such treatment which comprises administration to the human of a therapeutically effective amount of a compound of formula (I) including , enantiomers and pharmaceutically acceptable salts thereof in which R1 and R2 , are independently H or methyl and a therapeutically effective amount of a lipase inhibitor with the exception of orlistat; wherein the compound of formula (I) and the lipase inhibitor are administered simultaneously separately or sequentially.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 16, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 16, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 16, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.